3.1. Entry Submission
By submitting an Entry, the Participant accepts these Terms.
Entries must be submitted via the Competition email address and must
include all information required, including but not limited to:
- Participant (and, if applicable, Participant Team) name,
email, phone number, and mailing address;
- Team size and
company composition including leadership team;
rationale for proposed research project including description of
relevant data generated and scientific progress to date;
- Proposed research project including project plan, timelines and
- Total funding at time of application;
- Relevant IP rights;
- Anticipated benefits of securing
the Co-creation Greenhouse;
- Confirmation that the
Participant has read and understood the terms and conditions.
Entries may be submitted at any time during the Open Call Period. An
Entry is not complete unless and until the Entry criteria above are
properly followed. Submitted entries will not be returned.
Entries will be considered non-confidential. By submitting an Entry,
Participant acknowledges and agrees that the Entry will not be treated
as confidential. Participant is advised, before submitting an Entry,
to consult a lawyer or patent attorney as to the desirability of
seeking patents or other protection for the Entry.
By submitting an Entry, Participant warrants and represents that:
i. The Entry is the original work of Participant;
ii. Participant and, if applicable,
Participant Team, has consented to the submission and use of the Entry
in the Competition;
iii. The Entry does not contain any
copyrighted material not owned by Participant or, if applicable,
Participant Team and, to the best of Participant’s knowledge, does not
infringe the rights of any third party, including but not limited to
rights of publicity or privacy, moral rights, or any other property rights;
iv. Participant has the right to
present the Entry and to participate in the Competition and there are
no claims, judgments or settlements against or owed by Participant
relating to the Entry or any information contained therein;
v. The Entry only contains
names/likeness/identifying elements of persons for the use of which
these persons have given their prior written consent to Participant.
In the Entry, Participant must disclose whether:
a) Participant has any currently
active formal partnerships with other pharmaceutical companies;
b) Participant is a Health Care
Participant’s submission of the Entry is at its own responsibility
and risk. Novo Nordisk shall not be liable for loss of data or illegal
intrusion into its systems by third parties.
3.2 Review of Entries
The entries will be judged and scored by a review panel chosen by
Novo Nordisk (“Review Panel”).
The Review Panel will rank the entries based on criteria fit for a
- Quality, feasibility, and scale of proposed solution or
- The description of the unique technical features
of the product or service, the proposed benefits to stakeholders,
any evidence or proof-of-concept supporting the impact of the
solution, and the ability to scale to a broad market.
- Scientific rationale
- The description of scientific
rationale behind the proposed project
- Capability of
Participant to develop and execute solution
- A description
of the composition of the Participant Team and relevant background
and experience of Participant or each Participant Team member that
uniquely positions Participant to execute on this solution.
Novo Nordisk reserves the right to assess the entries in a manner
determined by Novo Nordisk, which may include interviews or
discussions with certain Participants.
3.3 Selection of Participants
As many as ten of the entries ranked highest by the Review Panel
will be selected to progress (referred to as “Selected
Participants”), subject to verification and compliance with these
Terms. The Selected Participants will be notified by the email address
they provided by November 29, 2021.
If an email notification is returned as undeliverable, or if
Selected Participants do not respond within the required number of
days specified by Novo Nordisk, or if any information submitted by
Participant is found in non-compliance with the Terms, raises
significant concern to Novo Nordisk, or if potential Selected
Participants decide to decline selection as Selected Participants for
any reason, Novo Nordisk shall have no further obligations to such
Selected Participants and a place as Selected Participants may instead
be awarded to a runner-up Selected Participant, time-permitting and at
Novo Nordisk’s sole discretion.
The Selected Participants may receive questions or other feedback
from Novo Nordisk after being selected as Selected Participants.
3.4. Selection of Winners
By December 7, 2021, the Selected Participants will present their
proposed research project to the Review Panel in a meeting where Novo
Nordisk will provide feedback to the Selected Participants’ project
proposal. Based on the outcome of this meeting, Novo Nordisk may
choose not to move forward with any Selected Participants in the
competition. In such case, Novo Nordisk will make reasonable efforts
to notify the Selected Participants by email within 2 days of the meeting.
Based on the feedback provided by Novo Nordisk, the Selected
Participants are allowed to revise their proposed research project in
order to achieve better fit with the Co-creation Greenhouse model.
By December 16, 2021, the Selected Participants will present their
final proposed research project to the Review Panel in a review
meeting where Novo Nordisk will judge the Selected Participants’ final
project. Novo Nordisk can select up to three (3) winners of the
Co-creation Greenhouse (the “Winners”). Novo Nordisk may elect
not to select any Winners.
To be eligible to win the Co-creation Greenhouse, the Winner must be
a duly incorporated legal entity with a US federal tax number.
The Co-creation Greenhouse Winner will receive: (i) a research grant
of 50,000 USD, (ii) an offer of mentoring from a Novo Nordisk
scientist for up to three (3) hours per week over a six (6) months
period and (iii) in-kind support, as deemed necessary by Novo Nordisk,
for achieving the agreed research goals.
The research grant of 50,000 USD will be paid in monthly
installments over a six (6) months period. The research grant may only
be spent as agreed with Novo Nordisk in the research project plan. The
research grant may not be spent on travel costs.
The Winner will be notified via the email address they provided by
December 16, 2021.
If an email notification is returned as undeliverable, if a Winner
does not respond within the required number of days specified by Novo
Nordisk, if any information submitted by Participant is found in
non-compliance with the Terms or raises significant concern to Novo
Nordisk in Novo Nordisk’s sole discretion, or if a Winner decides to
decline the prize for any reason, Novo Nordisk shall have no further
obligations to such Winner and the applicable prize will be forfeited
and may be awarded to a runner-up Winner, time-permitting and at Novo
Nordisk’s sole discretion.
If, once selected as a Winner, a Selected Participant is of the
opinion that their solution cannot be further discussed or developed
without the disclosure of any confidential or proprietary information,
Novo Nordisk may decide to enter into a confidentiality agreement with
Participant to ensure that the mutual interests are well protected.
The Co-creation Greenhouse is non-transferable and substitutions or
cash redemptions will not be allowed. Except where prohibited by law,
all tax liabilities are the responsibility of the Co-creation
Greenhouse Winner. Novo Nordisk will not be responsible for any tax
deductions which may be necessary. Participant acknowledges that
he/she will not be entitled to any additional payment by reason of any
award(s) being subject to any tax, levy, or other charge in any jurisdiction.
The Co-creation Greenhouse Winner is responsible for any additional
costs and expenses associated with the acceptance and/or use of the
Co-creation Greenhouse. All details of the prize not specified in
these Terms shall be determined by Novo Nordisk in its sole discretion.